Skip to main content

Advertisement

Table 1 Organ absorbed doses and contributions to effective doses for 11C-Cimbi-36 and 11C-Cimbi-36_5

From: Human biodistribution and radiation dosimetry of the 5-HT2A receptor agonist Cimbi-36 labeled with carbon-11 in two positions

  Absorbed dose
(μGy/MBq)
Contributions to effective dose
(μSv/MBq)
Target organ 11C-Cimbi-36 11C-Cimbi-36_5 11C-Cimbi-36 11C-Cimbi-36_5
Adrenals 5.83 5.52 0.05 0.05
Brain 6.12 6.72 0.06 0.07
Breasts 2.38 2.42 0.29 0.29
Esophagus 3.54 3.50 0.14 0.14
Eyes 2.19 2.32 0.00 0.00
Gallbladder wall 5.85 4.88 0.05 0.05
Left colon 5.24 5.70 0.25 0.28
Small intestine 5.55 4.91 0.05 0.05
Stomach wall 5.46 7.56 0.66 0.91
Right colon 3.23 3.15 0.16 0.15
Rectum 2.99 2.57 0.07 0.06
Heart wall 10.70 9.84 0.10 0.09
Kidneys 11.80 10.50 0.11 0.10
Liver 15.70 13.20 0.63 0.53
Lungs 8.61 8.31 1.03 1.00
Ovaries 3.14 2.91 0.13 0.12
Pancreas 13.30 11.60 0.12 0.11
Prostate 2.67 2.29 0.01 0.01
Salivary glands 2.36 2.48 0.02 0.02
Red marrow 4.19 4.33 0.50 0.52
Osteogenic cells 3.37 3.72 0.03 0.04
Spleen 18.40 17.90 0.17 0.17
Testes 1.89 1.87 0.08 0.07
Thymus 3.20 3.21 0.03 0.03
Thyroid 6.37 6.52 0.26 0.26
Urinary bladder wall 12.40 2.40 0.50 0.10
Uterus 3.51 2.85 0.02 0.01
Effective dose    5.5 5.3